{"parse":{"title":"African Malaria Network Trust","pageid":15673410,"revid":850892032,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox vcard\" style=\"width:22em\"><caption class=\"fn org\">African Malaria Network Trust\n\n<a href=\"/wiki/Acronyms_in_healthcare\" title=\"Acronyms in healthcare\">Acronym: AMANET</a></caption><tbody><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:AMANET_Logo.jpg\" class=\"image\"><img alt=\"AMANET Logo.jpg\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/1/1c/AMANET_Logo.jpg/180px-AMANET_Logo.jpg\" width=\"180\" height=\"103\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/1/1c/AMANET_Logo.jpg/270px-AMANET_Logo.jpg 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/1/1c/AMANET_Logo.jpg/360px-AMANET_Logo.jpg 2x\" data-file-width=\"416\" data-file-height=\"239\" /></a><div>Logo: African Malaria Network Trust</div></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Formation</th><td class=\"note\">\n14 March 2002</td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Type</th><td>\nInternational <a href=\"/wiki/NGO\" class=\"mw-redirect\" title=\"NGO\">NGO</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Headquarters</th><td>\n<a href=\"/wiki/Dar_es_Salaam\" title=\"Dar es Salaam\">Dar es Salaam</a>, <a href=\"/wiki/Tanzania\" title=\"Tanzania\">Tanzania</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Official language </div></th><td>\nEnglish</td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Managing <a href=\"/wiki/Trustee\" title=\"Trustee\">Trustee</a></div></th><td>\n<a href=\"/w/index.php?title=Wen_Kilama&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Wen Kilama (page does not exist)\">Prof. Wen Kilama</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Website</th><td>\n<span class=\"url\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.amanet-trust.org/\">www<wbr />.amanet-trust<wbr />.org</a></span></td></tr></tbody></table>\n<p>The <b>African Malaria Network Trust</b> (<b>AMANET</b>) is a pan-African international <a href=\"/wiki/NGO\" class=\"mw-redirect\" title=\"NGO\">NGO</a> headquartered in <a href=\"/wiki/Dar_es_Salaam\" title=\"Dar es Salaam\">Dar es Salaam</a>, <a href=\"/wiki/Tanzania\" title=\"Tanzania\">Tanzania</a> which originally started its activities as African Malaria Vaccine Testing Network (AMVTN) in 1995 with the primary goal of preparing Africa in planning and conducting <a href=\"/wiki/Malaria\" title=\"Malaria\">malaria</a> <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccine</a> trials. In order to widen the scope in malaria interventions, AMVTN was succeeded by AMANET on 14 March 2002. Although the primary goal of AMANET has remained malaria vaccine development, the organization in its expanded role includes other intervention measures such as antimalaria drugs and <a href=\"/wiki/Vector_control\" title=\"Vector control\">vector control</a>.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Precedence\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Precedence</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Establishment\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Establishment</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Mission\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Mission</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Broad_objective\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Broad objective</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Specific_objectives\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Specific objectives</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Organization_Structure\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Organization Structure</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Product_research_and_development\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Product research and development</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Capacity_strengthening\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Capacity strengthening</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#Building_institutional_capacities_in_Health_Research_Ethics_in_Africa\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Building institutional capacities in Health Research Ethics in Africa</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#The_Afro_Immuno_\u2013_Assay_(AIA)_Network\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">The Afro Immuno \u2013 Assay (AIA) Network</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Short_and_long-term_training\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">Short and long-term training</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#The_Multilateral_Initiative_on_Malaria_(MIM)\"><span class=\"tocnumber\">12</span> <span class=\"toctext\">The Multilateral Initiative on Malaria (MIM)</span></a></li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#Acknowledgements\"><span class=\"tocnumber\">13</span> <span class=\"toctext\">Acknowledgements</span></a></li>\n<li class=\"toclevel-1 tocsection-14\"><a href=\"#References\"><span class=\"tocnumber\">14</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-15\"><a href=\"#External_links\"><span class=\"tocnumber\">15</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Precedence\">Precedence</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=1\" title=\"Edit section: Precedence\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Saving_Lives_with_SMS_for_Life.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/46/Saving_Lives_with_SMS_for_Life.jpg/220px-Saving_Lives_with_SMS_for_Life.jpg\" width=\"220\" height=\"165\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/46/Saving_Lives_with_SMS_for_Life.jpg/330px-Saving_Lives_with_SMS_for_Life.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/46/Saving_Lives_with_SMS_for_Life.jpg/440px-Saving_Lives_with_SMS_for_Life.jpg 2x\" data-file-width=\"2700\" data-file-height=\"2025\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Saving_Lives_with_SMS_for_Life.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Malaria Clinic in Tanzania helped by <a href=\"/wiki/Extreme_Blue#Projects\" title=\"Extreme Blue\">SMS for Life</a> program</div></div></div>\n<p><a href=\"/wiki/Malaria\" title=\"Malaria\">Malaria</a> is a preventable disease that afflicts hundreds of millions of people causing among them untoward socio-economic suffering including a vicious cycle of abject poverty, brain damage, other irreversible disabilities, and over one million deaths per year.<sup id=\"cite_ref-Global_Malaria_Situation:World_Malaria_Report_2005_1-0\" class=\"reference\"><a href=\"#cite_note-Global_Malaria_Situation:World_Malaria_Report_2005-1\">&#91;1&#93;</a></sup> Notwithstanding this leading disease burden, malaria has yet to get the status it deserves on the political and other relevant agenda of endemic communities and development partners.\n</p><p>For centuries, malaria has adversely affected the history of sub-Saharan Africa; its control during the past century however concentrated on urban areas where colonial authorities and traders lived and in agricultural estates and mines whose products sustained industries in the colonizing countries. When the global malaria eradication program was showing signs of success, which coincided with the wave of national independence, the eradication program was abandoned in Africa on the pretext of mainly administrative and financial constraints. However, the strategies were continued elsewhere.<sup id=\"cite_ref-Malaria_in_2002_2-0\" class=\"reference\"><a href=\"#cite_note-Malaria_in_2002-2\">&#91;2&#93;</a></sup> As a consequence, the malaria situation in Africa worsened; now Africa bears the brunt of the world malaria burden estimated at 500 million malaria cases and up to 3 million malaria deaths per annum, and costing an estimated US$12 billion annually.<sup id=\"cite_ref-The_economic_and_social_burden_of_malaria_3-0\" class=\"reference\"><a href=\"#cite_note-The_economic_and_social_burden_of_malaria-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-The_ears_of_the_hippopotamus:_manifestations,_determinants,_and_estimates_of_the_malaria_burden_4-0\" class=\"reference\"><a href=\"#cite_note-The_ears_of_the_hippopotamus:_manifestations,_determinants,_and_estimates_of_the_malaria_burden-4\">&#91;4&#93;</a></sup>\n</p><p>Continued failure of current strategies (prompt diagnosis, early correct treatment, and the use of insecticide treated nets (ITNs) calls for a need to develop entirely new tools that would contribute to the fight of a resilient enemy and reverse its devastation. Over the last three decades there has been considerable interest in research and development of malaria vaccines. Research results that have been obtained so far show that malaria vaccine candidates would differ not only in their biological properties, but also in their eventual applications.<sup id=\"cite_ref-Corrigendum:_Engers,_H.D._and_Godal,_T._Malaria_vaccine_development:_current_status._Parasitol._Today_14,_56-64,_1998_5-0\" class=\"reference\"><a href=\"#cite_note-Corrigendum:_Engers,_H.D._and_Godal,_T._Malaria_vaccine_development:_current_status._Parasitol._Today_14,_56-64,_1998-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-Africa_must_engage_directly_in_fight_against_malaria_6-0\" class=\"reference\"><a href=\"#cite_note-Africa_must_engage_directly_in_fight_against_malaria-6\">&#91;6&#93;</a></sup>\n<a href=\"/wiki/Vaccines\" class=\"mw-redirect\" title=\"Vaccines\">Vaccines</a> have been exceptionally effective against a number of diseases and have become one of the safest and most cost-effective weapons in medicine's arsenal against <a href=\"/wiki/Communicable_disease\" class=\"mw-redirect\" title=\"Communicable disease\">communicable disease</a>. Perhaps no other intervention has had such a dramatic impact on the health and well-being of our society as the introduction of vaccines.\n</p>\n<h2><span class=\"mw-headline\" id=\"Establishment\">Establishment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=2\" title=\"Edit section: Establishment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In 1995 at a conference held in Arusha, Tanzania, 81 malaria researchers from Africa, Europe and North America established the African Malaria Vaccine Testing Network (AMVTN) in order to prepare Africa for planning, undertaking and coordinating malaria vaccine trials In order to widen the scope in malaria interventions, and to operate within a legal framework, AMVTN was succeeded by AMANET in 2002. Although the primary goal of AMANET has remained malaria vaccine development, in its expanded role the organization would also support study into other intervention approaches such as antimalarial drugs, diagnostics and vector control. AMANET is committed to the creation of an environment for enabling the development of African centres of excellence in malaria research through capacity strengthening of African scientists and institutions.<sup id=\"cite_ref-Towards_an_African-driven_malaria_vaccine_development_program:_history_and_activities_of_the_African_Malaria_Network_Trust_(AMANET)_7-0\" class=\"reference\"><a href=\"#cite_note-Towards_an_African-driven_malaria_vaccine_development_program:_history_and_activities_of_the_African_Malaria_Network_Trust_(AMANET)-7\">&#91;7&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Mission\">Mission</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=3\" title=\"Edit section: Mission\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The mission of AMANET is to promote capacity strengthening and networking of malaria <a href=\"/wiki/R%26D\" class=\"mw-redirect\" title=\"R&amp;D\">R&amp;D</a> in Africa\n</p>\n<h2><span class=\"mw-headline\" id=\"Broad_objective\">Broad objective</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=4\" title=\"Edit section: Broad objective\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>To continue developing self-sustainable centres in Africa that meet international requirements for conducting malaria intervention trials.\n</p>\n<h2><span class=\"mw-headline\" id=\"Specific_objectives\">Specific objectives</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=5\" title=\"Edit section: Specific objectives\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>To develop and support implementation of standards for the expertise and infrastructure required to perform and to evaluate intervention trials</li>\n<li>To promote and coordinate capacity strengthening activities of African malaria R&amp;D institutions</li>\n<li>To further develop previously selected centres for clinical trials so as to attain sustainability</li>\n<li>To select more centres for future strengthening for more clinical trials</li>\n<li>To support long-term training of research personnel</li>\n<li>To develop suitable training programmes in accordance with international standards</li>\n<li>To fill gaps in infrastructure of the selected centres</li>\n<li>To disseminate information of AMANET activities</li>\n<li>To facilitate and promote the conducting of intervention trials</li>\n<li>To sponsor clinical and field trials</li>\n<li>To promote development of African indigenous antimalaria medicines</li>\n<li>To promote development of appropriate malaria diagnostics</li>\n<li>To establish a data management centres for AMANET funded trials</li>\n<li>To review AMANET constitution, and elect members of different AMANET governing bodies.</li></ul>\n<h2><span class=\"mw-headline\" id=\"Organization_Structure\">Organization Structure</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=6\" title=\"Edit section: Organization Structure\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The organization structure of AMANET comprises the General Assembly, Board of Trustees, the Secretariat, Scientific Coordinating Committee, Scientific Advisory Panel, Trial Sites Development Committee and Expert Committees.\n</p><p>The <b>General Assembly</b> comprising representatives of malaria R&amp;D institutions in Africa and allied institutions outside Africa is the topmost organ. It generally meets every two years and is responsible for electing the Board of Trustees and the Scientific Coordinating Committee.\n</p><p>The <b>Board of Trustees</b> is the ultimate authority in matters of policy and investment. It oversees the general governance, regulation and control of AMANET.\n</p><p>The <b>Scientific Coordinating Committee</b> is constituted of senior research scientists elected by the General Assembly. It is responsible for receiving and reviewing reports from the Secretariat and from the Expert Committees. The SCC advises the BoT on scientific matters. Its functions also include the reviewing of research proposals and letters of expression of interest and the monitoring and evaluation of ongoing and completed research projects.\n</p><p>The Secretariat is the executive organ of the Trust, serving the Board of Trustees and all the committees.\n</p><p>The <b>Trial Sites Development Committee</b> (TSDC) a Committee of experts appointed by the Board of Trustees from SCC to advise AMANET on specific issues relating to the development of trial sites.\n</p><p>The <b>Scientific Advisory Panel</b> is a panel of experts from various disciplines from whom <i>ad hoc</i> Expert Committees are formed to advise AMANET on specific research and scientific issues.\n</p>\n<h2><span class=\"mw-headline\" id=\"Product_research_and_development\">Product research and development</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=7\" title=\"Edit section: Product research and development\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Among the cherished goals of AMANET is to develop sustainable human and infrastructure capacity for African owned and led institutions to undertake malaria vaccine trials that are appropriate for Africans living in malaria-endemic areas. The current focus is to support the creation of a spectrum of interventional tools, especially vaccines that are efficacious, acceptable, affordable and readily accessible. The following are AMANET's candidate malaria vaccine portfolio:\n</p>\n<ul><li>The Merozoite Surface Protein - Long Sythetic Peptide (MSP3 LSP),<sup id=\"cite_ref-A_Phase_Ib_Trial_of_MSP_3_LSP_in_1-2_Year_Old_Children_in_Burkina_Faso_(MSP3LSP)_8-0\" class=\"reference\"><a href=\"#cite_note-A_Phase_Ib_Trial_of_MSP_3_LSP_in_1-2_Year_Old_Children_in_Burkina_Faso_(MSP3LSP)-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-Phase_Ib_Trial_of_MSP3_LSP_in_Children_in_Tanzania_(MSP3TN)_9-0\" class=\"reference\"><a href=\"#cite_note-Phase_Ib_Trial_of_MSP3_LSP_in_Children_in_Tanzania_(MSP3TN)-9\">&#91;9&#93;</a></sup>  This is the leading product which has already been shown to be safe in adults in Africa. The vaccine is currently undergoing testing for safety in children both in Burkina Faso and shortly in Tanzania. Should the safety profile be established to be safe, the vaccine will be taken through phase IIb immunogenicity trials that would also establish the proof of limited efficacy</li>\n<li>The <a href=\"/wiki/Apical_membrane_antigen_1\" title=\"Apical membrane antigen 1\">Apical Membrane Antigen</a> (AMA1):<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> This the second vaccine in development and is now undergoing phase Ib evaluation in adults Mali. During the last quarter of 2007, an evaluation of the safety results was done, and AMA1 was found to be safe in African adults..</li>\n<li>The GMZ2:<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> The third vaccine in the portfolio was recently initiated in phase Ib adult study in Gabon. This product is expected to undergo a similar developmental pathway should it continue to have good results. This product is unique because it is a hybrid molecule with two potential targets on the malaria parasite; GLURP and MSP3.</li></ul>\n<p>It is expected that within the next three years several trials of these candidate vaccines shall be undertaken at the auspices of AMANET.  Other candidate vaccines which meet the required profile are welcome to the AMANET malaria vaccine development programme.\n</p>\n<h2><span class=\"mw-headline\" id=\"Capacity_strengthening\">Capacity strengthening</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=8\" title=\"Edit section: Capacity strengthening\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Human resource and infrastructure development for malaria interventions in Africa is of up most priority to AMANET. This goal is being realized through both short-term trainings as well as direct financial support of the core centres. AMANET conducts short-term trainings through various workshops conducted throughout Africa, around six times a year. Additionally AMANET supports long-term training of individuals from AMANET funded sites which include:\n</p>\n<ul><li><a href=\"/wiki/Tanzania\" title=\"Tanzania\">Tanzania</a>-National Institute for Medical Research (NIMR) Tanga: The programme has steadily continued. We are currently preparing the site for the first vaccine trial of MSP3 in children 1\u20132 years. The site characterization activities are near completion; Two staff members at the site are currently taking AMANET sponsored long term training programs at MSc and PhD level.</li>\n<li><a href=\"/wiki/Zambia\" title=\"Zambia\">Zambia</a>-Tropical Diseases Research Centre (TDRC) Ndola: The centre is on the capacity development programme having received a strengthening grant. Two AMANET sponsored students are completing the training masters level.</li>\n<li><a href=\"/wiki/Burkina_Faso\" title=\"Burkina Faso\">Burkina Faso</a>-Centre de National Recherch\u00e9 et de Formation sur le Paludisme (CNRFP) Ouagadougou: The site is currently conducting phase Ib trial of the MSP3 candidate vaccine. Two immunologists were sent to Netherlands for two weeks on specific training to transfer technology and establish cellular assays. This has led to technology transfer with their lab now able to handle the relevant immunological assays to support the clinical trials.</li>\n<li><a href=\"/wiki/Uganda\" title=\"Uganda\">Uganda</a>-The Makerere University: The site has become the newest to receive a grant from AMANET for capacity strengthening in preparation for vaccine trials. It has, in parallel, received a grant for ethics committee strengthening.</li></ul>\n<h2><span class=\"mw-headline\" id=\"Building_institutional_capacities_in_Health_Research_Ethics_in_Africa\">Building institutional capacities in Health Research Ethics in Africa</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=9\" title=\"Edit section: Building institutional capacities in Health Research Ethics in Africa\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>This is a new project at AMANET funded by the <a href=\"/wiki/Bill_and_Melinda_Gates_Foundation\" class=\"mw-redirect\" title=\"Bill and Melinda Gates Foundation\">Bill and Melinda Gates Foundation</a> aimed at strengthening Health Research Ethics (HRE) capacity in Africa. The project aims at ensuring that as the African populations are recruited into health research projects, the protection of their welfare and interests is enhanced. The HRE project has three parts: building Health Research Ethics capacity, online Health Research Ethics discussion forum and Ask the Expert/Ethicist.\n</p><p>The HRE capacity building project focuses on training <a href=\"/wiki/Ethics_committee\" title=\"Ethics committee\">ethics committee</a> members on Research Ethics in order to improve the ethical review process of committees that are mandated to safeguard the welfare of research participants. In order to concentrate on activities that have greater potential to strengthen the Ethics Committees, a baseline survey was conducted to identify area of weakness that need to be addressed. A cohort of 21 Ethics Committees is being enrolled in this project and will be involved in various activities aimed at addressing areas of weakness in the review process. These committees are being provided with a sub-grant to support infrastructure and administration at their committees.\n</p><p>Overall, activities are spread over a period of three years, and they include, besides capacity strengthening and infrastructure support, a series of eight Research Ethics training workshops, two of which will be in French (for the benefit of the participating Francophone countries). Through the workshops, <a href=\"/wiki/Standard_Operating_Procedures\" class=\"mw-redirect\" title=\"Standard Operating Procedures\">Standard Operating Procedures</a> (SOPs) will be developed/improved, and an additional workshop focussing on harmonization of SOPs will be organised. In addition, a workshop on Research Ethics will be organised specifically for investigators.\n</p><p>It is envisaged that overall the HRE capacity building programme will contribute towards the establishment of competent and independent Ethics Committees that have well-equipped offices, functional and harmonised SOPs, electronic databases and archiving systems, and trained members who network and interact through online discussion forum and workshops.\n</p>\n<h2><span id=\"The_Afro_Immuno_.E2.80.93_Assay_.28AIA.29_Network\"></span><span class=\"mw-headline\" id=\"The_Afro_Immuno_\u2013_Assay_(AIA)_Network\">The Afro Immuno \u2013 Assay (AIA) Network</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=10\" title=\"Edit section: The Afro Immuno \u2013 Assay (AIA) Network\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Afro Immuno-Assay Network, started by <a href=\"/w/index.php?title=AMANET&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"AMANET (page does not exist)\">AMANET</a> in 2003, has been working on developing standardized immunological <a href=\"/wiki/Assays\" class=\"mw-redirect\" title=\"Assays\">assays</a> using the same reagents and statistical tools to assess the association between acquisition of malaria specific antibody responses starting with four potential malaria vaccine candidate antigens and subsequent protection from clinical malaria. This is a concerted network of eight African countries/Institutions with different geographical and epidemiological settings comprising low to <a href=\"/wiki/Holoendemic\" title=\"Holoendemic\">holoendemic</a> malaria and three supporting European institutions. Now the AIA network is under a new five-year project, within the European Malaria Vaccine Development Association (EMVDA) Consortium. In this Integrated Project, the AIA network focuses on standardization and validation of its immunological assays, expand to include new partners, further training for participating African immunologists and enhancement of laboratory expertise to include functional assays required for malaria vaccine evaluation.\n</p>\n<h2><span class=\"mw-headline\" id=\"Short_and_long-term_training\">Short and long-term training</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=11\" title=\"Edit section: Short and long-term training\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>During the first Strategic Planning period, AMANET supported and organized several training workshops which benefited over 1000 African malaria researchers and associated personnel.  In the process a comprehensive repository of expertise essential for the evaluation of malaria interventions, is being built up. Some of the former AMANET trainees have become experts in these areas. During this strategic plan period, AMANET will draw upon this vast expertise to constitute teams of trainers that facilitate short term training for AMANET beneficiary institutions, and for others upon request. The training will be in such areas as Health Research Ethics review in Africa; development of <a href=\"/wiki/Standard_Operating_Procedures\" class=\"mw-redirect\" title=\"Standard Operating Procedures\">Standard Operating Procedures</a> for Ethical Review Committee; Health Research Ethics for Investigators; <a href=\"/wiki/Good_Laboratory_Practice\" class=\"mw-redirect\" title=\"Good Laboratory Practice\">Good Laboratory Practice</a> and Standard Operating Procedures; <a href=\"/wiki/Good_clinical_practice\" title=\"Good clinical practice\">Good clinical practice</a>; Good Clinical Practice for African clinical monitors; Design, methodology and data management in intervention trials; Roles and operations of <a href=\"/wiki/Data_Safety_Monitoring_Boards\" class=\"mw-redirect\" title=\"Data Safety Monitoring Boards\">Data Safety Monitoring Boards</a> (DSMB).\n</p><p>Given the ever-rising demands for AMANET short-term training, alternative teaching methods have been developed and are being utilized. Web-based training on health research ethics (HRE) is in good progress. The AMANET HRE web-based course has been very successfully accessed through the AMANET website. The online course was launched in September 2006 and to date over 150 participants have successfully completed the course and over 430 candidates have registered for the course. Participants have been drawn from Africa, Europe and the US. Based on its success, AMANET has acquired other resources to continue the project and also the e-learning funding in order to continue the project another year and also expand the e-learning opportunities to include other courses such a GCP, French version of the same course, and also an Advanced Ethics Course.\n</p>\n<h2><span id=\"The_Multilateral_Initiative_on_Malaria_.28MIM.29\"></span><span class=\"mw-headline\" id=\"The_Multilateral_Initiative_on_Malaria_(MIM)\">The Multilateral Initiative on Malaria (MIM)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=12\" title=\"Edit section: The Multilateral Initiative on Malaria (MIM)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>From January 2006, AMANET became host to the Multilateral Initiative on Malaria (MIM) Secretariat. This is a global alliance of individuals, funding partners and four autonomous constituents comprising the MIM Secretariat, MIM/TDR, MIMCom and MR4. Its mission is to strengthen and sustain, through collaborative research and training, to carry out research that is required to develop and improve tools for malaria control, and to strengthen the research control interphase.\n</p>\n<h2><span class=\"mw-headline\" id=\"Acknowledgements\">Acknowledgements</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=13\" title=\"Edit section: Acknowledgements\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>AMANET acknowledges financial support from the <a href=\"/wiki/Ministry_of_Foreign_Affairs_(Netherlands)\" title=\"Ministry of Foreign Affairs (Netherlands)\">Ministry of Foreign Affairs (Netherlands)</a>, the Danish International Development Agency (<a href=\"/wiki/DANIDA\" class=\"mw-redirect\" title=\"DANIDA\">DANIDA</a>), the <a href=\"/wiki/European_Commission\" title=\"European Commission\">European Commission</a>\u2019s Directorate-General Research and AIDCO, the <a href=\"/wiki/Bill_and_Melinda_Gates_Foundation\" class=\"mw-redirect\" title=\"Bill and Melinda Gates Foundation\">Bill and Melinda Gates Foundation</a>,<sup id=\"cite_ref-Malaria_Grant:_African_Malaria_Network_Trust_(AMANET)_12-0\" class=\"reference\"><a href=\"#cite_note-Malaria_Grant:_African_Malaria_Network_Trust_(AMANET)-12\">&#91;12&#93;</a></sup> the <a href=\"/wiki/European_and_Developing_Countries_Clinical_Trials_Partnership\" title=\"European and Developing Countries Clinical Trials Partnership\">European and Developing Countries Clinical Trials Partnership</a>(EDCTP) and the African Caribbean Pacific (<a href=\"/wiki/ACP_Countries\" class=\"mw-redirect\" title=\"ACP Countries\">ACP</a>) Secretariat for including AMANET in their portfolio for EDF9 support.\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=14\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-Global_Malaria_Situation:World_Malaria_Report_2005-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Global_Malaria_Situation:World_Malaria_Report_2005_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.rbm.who.int/wmr2005/html/1-2.htm\">\"Global Malaria Situation:World Malaria Report 2005\"</a>. World Health Organization. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20080214054736/http://rbm.who.int/wmr2005/html/1-2.htm\">Archived</a> from the original on 14 February 2008<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-02-09</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Global+Malaria+Situation%3AWorld+Malaria+Report+2005&amp;rft.pub=World+Health+Organization&amp;rft_id=http%3A%2F%2Fwww.rbm.who.int%2Fwmr2005%2Fhtml%2F1-2.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Malaria_in_2002-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Malaria_in_2002_2-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Greenwood B, Mutabingwa T (February 2002). \"Malaria in 2002\". <i>Nature</i>. <b>415</b> (6872): 670\u20132. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/415670a\">10.1038/415670a</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11832954\">11832954</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Malaria+in+2002&amp;rft.volume=415&amp;rft.issue=6872&amp;rft.pages=670-2&amp;rft.date=2002-02&amp;rft_id=info%3Adoi%2F10.1038%2F415670a&amp;rft_id=info%3Apmid%2F11832954&amp;rft.aulast=Greenwood&amp;rft.aufirst=B&amp;rft.au=Mutabingwa%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-The_economic_and_social_burden_of_malaria-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-The_economic_and_social_burden_of_malaria_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\"><a href=\"/wiki/Jeffrey_Sachs\" title=\"Jeffrey Sachs\">Sachs J</a>, Malaney P (February 2002). \"The economic and social burden of malaria\". <i>Nature</i>. <b>415</b> (6872): 680\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/415680a\">10.1038/415680a</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11832956\">11832956</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=The+economic+and+social+burden+of+malaria&amp;rft.volume=415&amp;rft.issue=6872&amp;rft.pages=680-5&amp;rft.date=2002-02&amp;rft_id=info%3Adoi%2F10.1038%2F415680a&amp;rft_id=info%3Apmid%2F11832956&amp;rft.au=Sachs+J%2C+Malaney+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-The_ears_of_the_hippopotamus:_manifestations,_determinants,_and_estimates_of_the_malaria_burden-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-The_ears_of_the_hippopotamus:_manifestations,_determinants,_and_estimates_of_the_malaria_burden_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Breman JG (2001). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ajtmh.org/cgi/pmidlookup?view=long&amp;pmid=11425172\">\"The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden\"</a>. <i>Am. J. Trop. Med. Hyg</i>. <b>64</b> (1-2 Suppl): 1\u201311. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11425172\">11425172</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Trop.+Med.+Hyg.&amp;rft.atitle=The+ears+of+the+hippopotamus%3A+manifestations%2C+determinants%2C+and+estimates+of+the+malaria+burden&amp;rft.volume=64&amp;rft.issue=1-2+Suppl&amp;rft.pages=1-11&amp;rft.date=2001&amp;rft_id=info%3Apmid%2F11425172&amp;rft.au=Breman+JG&amp;rft_id=http%3A%2F%2Fwww.ajtmh.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11425172&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since March 2009\">dead link</span></a></i>&#93;</span></sup></span>\n</li>\n<li id=\"cite_note-Corrigendum:_Engers,_H.D._and_Godal,_T._Malaria_vaccine_development:_current_status._Parasitol._Today_14,_56-64,_1998-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Corrigendum:_Engers,_H.D._and_Godal,_T._Malaria_vaccine_development:_current_status._Parasitol._Today_14,_56-64,_1998_5-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Engers H (May 1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/S0169-4758(98)01236-8\">\"Corrigendum: Engers, H.D. and Godal, T. Malaria vaccine development: current status. Parasitol. Today 14, 56-64, 1998\"</a>. <i>Parasitol. Today (Regul. Ed.)</i>. <b>14</b> (5): 192. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0169-4758%2898%2901236-8\">10.1016/S0169-4758(98)01236-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17040749\">17040749</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parasitol.+Today+%28Regul.+Ed.%29&amp;rft.atitle=Corrigendum%3A+Engers%2C+H.D.+and+Godal%2C+T.+Malaria+vaccine+development%3A+current+status.+Parasitol.+Today+14%2C+56-64%2C+1998&amp;rft.volume=14&amp;rft.issue=5&amp;rft.pages=192&amp;rft.date=1998-05&amp;rft_id=info%3Adoi%2F10.1016%2FS0169-4758%2898%2901236-8&amp;rft_id=info%3Apmid%2F17040749&amp;rft.au=Engers+H&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0169-4758%2898%2901236-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Africa_must_engage_directly_in_fight_against_malaria-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Africa_must_engage_directly_in_fight_against_malaria_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.scidev.net/Opinions/index.cfm?fuseaction=readOpinions&amp;itemid=452&amp;language=1\">\"Africa must engage directly in fight against malaria\"</a>. SciDevNet<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-02-09</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Africa+must+engage+directly+in+fight+against+malaria&amp;rft.pub=SciDevNet&amp;rft_id=http%3A%2F%2Fwww.scidev.net%2FOpinions%2Findex.cfm%3Ffuseaction%3DreadOpinions%26itemid%3D452%26language%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Towards_an_African-driven_malaria_vaccine_development_program:_history_and_activities_of_the_African_Malaria_Network_Trust_(AMANET)-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Towards_an_African-driven_malaria_vaccine_development_program:_history_and_activities_of_the_African_Malaria_Network_Trust_(AMANET)_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kilama WL, Chilengi R, Wanga CL (December 2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ajtmh.org/cgi/content/full/77/6_Suppl/282\">\"Towards an African-driven malaria vaccine development program: history and activities of the African Malaria Network Trust (AMANET)\"</a>. <i>Am. J. Trop. Med. Hyg</i>. <b>77</b> (6 Suppl): 282\u20138. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18165504\">18165504</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Trop.+Med.+Hyg.&amp;rft.atitle=Towards+an+African-driven+malaria+vaccine+development+program%3A+history+and+activities+of+the+African+Malaria+Network+Trust+%28AMANET%29&amp;rft.volume=77&amp;rft.issue=6+Suppl&amp;rft.pages=282-8&amp;rft.date=2007-12&amp;rft_id=info%3Apmid%2F18165504&amp;rft.aulast=Kilama&amp;rft.aufirst=WL&amp;rft.au=Chilengi%2C+R&amp;rft.au=Wanga%2C+CL&amp;rft_id=http%3A%2F%2Fwww.ajtmh.org%2Fcgi%2Fcontent%2Ffull%2F77%2F6_Suppl%2F282&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-A_Phase_Ib_Trial_of_MSP_3_LSP_in_1-2_Year_Old_Children_in_Burkina_Faso_(MSP3LSP)-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-A_Phase_Ib_Trial_of_MSP_3_LSP_in_1-2_Year_Old_Children_in_Burkina_Faso_(MSP3LSP)_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://clinicaltrials.gov/ct2/show/NCT00452088?spons=%22African+Malaria+Network+Trust%22&amp;spons_ex=Y&amp;rank=4\">\"A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso (MSP3LSP)\"</a>. ClinicalTrial.gov<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-02-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Phase+Ib+Trial+of+MSP+3+LSP+in+1-2+Year+Old+Children+in+Burkina+Faso+%28MSP3LSP%29&amp;rft.pub=ClinicalTrial.gov&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00452088%3Fspons%3D%2522African%2BMalaria%2BNetwork%2BTrust%2522%26spons_ex%3DY%26rank%3D4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Phase_Ib_Trial_of_MSP3_LSP_in_Children_in_Tanzania_(MSP3TN)-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Phase_Ib_Trial_of_MSP3_LSP_in_Children_in_Tanzania_(MSP3TN)_9-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://clinicaltrials.gov/ct2/show/NCT00469651?spons=%22African+Malaria+Network+Trust%22&amp;spons_ex=Y&amp;rank=3\">\"Phase Ib Trial of MSP3 LSP in Children in Tanzania (MSP3TN)\"</a>. ClinicalTrial.gov<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-02-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Phase+Ib+Trial+of+MSP3+LSP+in+Children+in+Tanzania+%28MSP3TN%29&amp;rft.pub=ClinicalTrial.gov&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00469651%3Fspons%3D%2522African%2BMalaria%2BNetwork%2BTrust%2522%26spons_ex%3DY%26rank%3D3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://clinicaltrials.gov/ct2/show/NCT00431808?spons=%22African+Malaria+Network+Trust%22&amp;spons_ex=Y&amp;rank=1\">\"Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO&#91;25-545&#93;)\"</a>. ClinicalTrial.gov<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-02-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Safety+and+Immunogenicity+of+Apical+Membrane+Antigen+1+%28PfAMA-1-FVO%26%2391%3B25-545%26%2393%3B%29&amp;rft.pub=ClinicalTrial.gov&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00431808%3Fspons%3D%2522African%2BMalaria%2BNetwork%2BTrust%2522%26spons_ex%3DY%26rank%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://clinicaltrials.gov/ct2/show/NCT00424944?spons=%22African+Malaria+Network+Trust%22&amp;spons_ex=Y&amp;rank=2\">\"Safety of Recombinant Hybrid GMZ 2 &#91;GLURP + MSP 3&#93; Blood Stage Malaria Vaccine\"</a>. ClinicalTrial.gov<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-02-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Safety+of+Recombinant+Hybrid+GMZ+2+%26%2391%3BGLURP+%2B+MSP+3%26%2393%3B+Blood+Stage+Malaria+Vaccine&amp;rft.pub=ClinicalTrial.gov&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00424944%3Fspons%3D%2522African%2BMalaria%2BNetwork%2BTrust%2522%26spons_ex%3DY%26rank%3D2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Malaria_Grant:_African_Malaria_Network_Trust_(AMANET)-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Malaria_Grant:_African_Malaria_Network_Trust_(AMANET)_12-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://archive.is/20070629153954/http://www.gatesfoundation.org/GlobalHealth/Pri_Diseases/Malaria/Grants/Grant-37350.htm\">\"Malaria Grant: African Malaria Network Trust (AMANET)\"</a>. Bill &amp; Melinda Gates Foundation. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.gatesfoundation.org/GlobalHealth/Pri_Diseases/Malaria/Grants/Grant-37350.htm\">the original</a> on 2007-06-29<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-02-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Malaria+Grant%3A+African+Malaria+Network+Trust+%28AMANET%29&amp;rft.pub=Bill+%26+Melinda+Gates+Foundation&amp;rft_id=http%3A%2F%2Fwww.gatesfoundation.org%2FGlobalHealth%2FPri_Diseases%2FMalaria%2FGrants%2FGrant-37350.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAfrican+Malaria+Network+Trust\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> </span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=African_Malaria_Network_Trust&amp;action=edit&amp;section=15\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><span class=\"official-website\"><span class=\"url\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.amanet-trust.org/\">Official website</a></span></span> <a href=\"https://www.wikidata.org/wiki/Q4689852#P856\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Malaria\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\" style=\"background:Silver\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Malaria\" title=\"Template:Malaria\"><abbr title=\"View this template\" style=\";background:Silver;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Malaria\" title=\"Template talk:Malaria\"><abbr title=\"Discuss this template\" style=\";background:Silver;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Malaria&amp;action=edit\"><abbr title=\"Edit this template\" style=\";background:Silver;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Malaria\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Malaria\" title=\"Malaria\">Malaria</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Biology</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Malaria\" title=\"Malaria\">Malaria</a>\n<ul><li><a href=\"/wiki/Cerebral_malaria\" class=\"mw-redirect\" title=\"Cerebral malaria\">Cerebral</a></li>\n<li><a href=\"/wiki/Blackwater_fever\" title=\"Blackwater fever\">Blackwater fever</a></li>\n<li><a href=\"/wiki/Pregnancy-associated_malaria\" title=\"Pregnancy-associated malaria\">Pregnancy-associated</a></li></ul></li>\n<li><a href=\"/wiki/Plasmodium\" title=\"Plasmodium\">Plasmodium</a>\n<ul><li><a href=\"/wiki/Plasmodium_falciparum\" title=\"Plasmodium falciparum\">biology</a></li>\n<li><a href=\"/wiki/Plasmodium_(life_cycle)\" title=\"Plasmodium (life cycle)\">life cycle</a></li>\n<li><i><a href=\"/wiki/Plasmodium_vivax\" title=\"Plasmodium vivax\">vivax</a></i></li>\n<li><i><a href=\"/wiki/Plasmodium_falciparum\" title=\"Plasmodium falciparum\">falciparum</a></i></li>\n<li><i><a href=\"/wiki/Plasmodium_ovale\" title=\"Plasmodium ovale\">ovale</a></i></li>\n<li><i><a href=\"/wiki/Plasmodium_malariae\" title=\"Plasmodium malariae\">malariae</a></i></li>\n<li><i><a href=\"/wiki/Plasmodium_knowlesi\" title=\"Plasmodium knowlesi\">knowlesi</a></i></li></ul></li>\n<li><a href=\"/wiki/Anopheles\" title=\"Anopheles\">Anopheles mosquito</a></li>\n<li><a href=\"/wiki/Biological_life_cycle\" title=\"Biological life cycle\">Lifecycle</a>\n<ul><li><a href=\"/wiki/Schizont\" class=\"mw-redirect\" title=\"Schizont\">Schizont</a></li>\n<li><a href=\"/wiki/Merozoite\" class=\"mw-redirect\" title=\"Merozoite\">Merozoite</a></li>\n<li><a href=\"/wiki/Hypnozoite\" class=\"mw-redirect\" title=\"Hypnozoite\">Hypnozoite</a></li>\n<li><a href=\"/wiki/Gametocyte\" title=\"Gametocyte\">Gametocyte</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Control and prevention</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Public_health\" title=\"Public health\">Public health</a>\n<ul><li><a href=\"/wiki/DDT\" title=\"DDT\">DDT</a></li>\n<li><a href=\"/wiki/Mosquito_net\" title=\"Mosquito net\">Mosquito net</a></li>\n<li><a href=\"/wiki/Malaria_prophylaxis\" title=\"Malaria prophylaxis\">Malaria prophylaxis</a></li>\n<li><a href=\"/wiki/Mosquito_control\" title=\"Mosquito control\">Mosquito control</a></li>\n<li><a href=\"/wiki/Sterile_insect_technique\" title=\"Sterile insect technique\">Sterile insect technique</a></li></ul></li>\n<li><a href=\"/wiki/Genetic_resistance_to_malaria\" class=\"mw-redirect\" title=\"Genetic resistance to malaria\">Genetic resistance</a>\n<ul><li><a href=\"/wiki/Duffy_antigen\" class=\"mw-redirect\" title=\"Duffy antigen\">Duffy antigen</a></li>\n<li><a href=\"/wiki/Sickle-cell_anaemia\" class=\"mw-redirect\" title=\"Sickle-cell anaemia\">Sickle-cell anaemia</a></li>\n<li><a href=\"/wiki/Thalassemia\" title=\"Thalassemia\">Thalassemia</a></li>\n<li><a href=\"/wiki/G6PDH_deficiency\" class=\"mw-redirect\" title=\"G6PDH deficiency\">G6PDH deficiency</a></li></ul></li>\n<li><a href=\"/wiki/Malaria_vaccine\" title=\"Malaria vaccine\">Malaria vaccine</a>\n<ul><li><a href=\"/wiki/RTS,S\" title=\"RTS,S\">RTS,S</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Diagnosis and treatment</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Diagnosis_of_malaria\" title=\"Diagnosis of malaria\">Diagnosis of malaria</a>\n<ul><li><a href=\"/wiki/Malaria_culture\" title=\"Malaria culture\">Malaria culture</a></li>\n<li><a href=\"/wiki/Blood_film\" title=\"Blood film\">Blood film</a></li>\n<li><a href=\"/wiki/Malaria_antigen_detection_tests\" title=\"Malaria antigen detection tests\">Malaria antigen detection tests</a></li></ul></li></ul>\n<ul><li><a href=\"/wiki/Antimalarial_medication\" title=\"Antimalarial medication\">Antimalarials</a>\n<ul><li><a href=\"/wiki/Artemisinin\" title=\"Artemisinin\">Artemisinin</a></li>\n<li><a href=\"/wiki/Mefloquine\" title=\"Mefloquine\">Mefloquine</a></li>\n<li><a href=\"/wiki/Proguanil\" title=\"Proguanil\">Proguanil</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Society and malaria</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Diseases_of_poverty\" title=\"Diseases of poverty\">Diseases of poverty</a></li>\n<li><a href=\"/wiki/Millennium_Development_Goals\" title=\"Millennium Development Goals\">Millennium Development Goals</a></li>\n<li><a href=\"/wiki/History_of_malaria\" title=\"History of malaria\">History of malaria</a>\n<ul><li><a href=\"/wiki/Timeline_of_malaria\" title=\"Timeline of malaria\">Timeline</a></li>\n<li><a href=\"/wiki/Roman_Fever_(disease)\" class=\"mw-redirect\" title=\"Roman Fever (disease)\">Roman fever</a></li>\n<li><a href=\"/wiki/National_Malaria_Eradication_Program\" title=\"National Malaria Eradication Program\">National Malaria Eradication Program</a></li></ul></li>\n<li><a href=\"/wiki/World_Malaria_Day\" title=\"World Malaria Day\">World Malaria Day</a></li>\n<li><a href=\"/wiki/Epidemiology\" title=\"Epidemiology\">Epidemiology</a>\n<ul><li><a href=\"/wiki/Malaria_and_the_Caribbean\" title=\"Malaria and the Caribbean\">Malaria and the Caribbean</a></li>\n<li><a href=\"/wiki/Malaria_Atlas_Project\" title=\"Malaria Atlas Project\">Malaria Atlas Project</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Organisations</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Roll_Back_Malaria_Partnership\" class=\"mw-redirect\" title=\"Roll Back Malaria Partnership\">Roll Back Malaria Partnership</a></li>\n<li><a href=\"/wiki/Malaria_Consortium\" title=\"Malaria Consortium\">Malaria Consortium</a></li>\n<li><a href=\"/wiki/Against_Malaria_Foundation\" title=\"Against Malaria Foundation\">Against Malaria Foundation</a></li>\n<li><a href=\"/wiki/Bill_%26_Melinda_Gates_Foundation\" title=\"Bill &amp; Melinda Gates Foundation\">Bill &amp; Melinda Gates Foundation</a></li>\n<li><a href=\"/wiki/Imagine_No_Malaria\" title=\"Imagine No Malaria\">Imagine No Malaria</a></li>\n<li><a href=\"/wiki/Malaria_No_More\" title=\"Malaria No More\">Malaria No More</a></li>\n<li><a href=\"/wiki/Africa_Fighting_Malaria\" title=\"Africa Fighting Malaria\">Africa Fighting Malaria</a></li>\n<li><a class=\"mw-selflink selflink\">African Malaria Network Trust</a></li>\n<li><a href=\"/wiki/South_African_Malaria_Initiative\" title=\"South African Malaria Initiative\">South African Malaria Initiative</a></li>\n<li><a href=\"/wiki/African_Leaders_Malaria_Alliance\" title=\"African Leaders Malaria Alliance\">African Leaders Malaria Alliance</a></li>\n<li><a href=\"/wiki/Amazon_Malaria_Initiative\" title=\"Amazon Malaria Initiative\">Amazon Malaria Initiative</a></li>\n<li><a href=\"/wiki/The_Global_Fund_to_Fight_AIDS,_Tuberculosis_and_Malaria\" title=\"The Global Fund to Fight AIDS, Tuberculosis and Malaria\">The Global Fund to Fight AIDS, Tuberculosis and Malaria</a></li>\n<li><a href=\"/wiki/Medicines_for_Malaria_Venture\" title=\"Medicines for Malaria Venture\">Medicines for Malaria Venture</a></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw1287\nCached time: 20180909000555\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.248 seconds\nReal time usage: 0.313 seconds\nPreprocessor visited node count: 1569/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 40816/2097152 bytes\nTemplate argument size: 1607/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 17598/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.111/10.000 seconds\nLua memory usage: 4.19 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  257.041      1 -total\n 52.00%  133.673      1 Template:Reflist\n 32.57%   83.720      1 Template:Infobox_Organization\n 26.12%   67.136      1 Template:Infobox\n 20.22%   51.983      7 Template:Cite_web\n 13.29%   34.154      1 Template:Dead_link\n 11.53%   29.634      1 Template:Fix\n 10.36%   26.639      2 Template:Category_handler\n  9.64%   24.783      5 Template:Cite_journal\n  8.45%   21.721      1 Template:Official_website\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:15673410-0!canonical and timestamp 20180909000555 and revision id 850892032\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_March_2009"},{"sortkey":"","*":"International_medical_and_health_organizations"},{"sortkey":"","*":"Organizations_established_in_2002"},{"sortkey":"","*":"Medical_and_health_organisations_based_in_Tanzania"},{"sortkey":"","*":"Malaria_organizations"},{"sortkey":"","*":"2002_establishments_in_Tanzania"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with dead external links from March 2009"},{"ns":10,"exists":"","*":"Template:Malaria"},{"ns":0,"exists":"","*":"ACP Countries"},{"ns":0,"exists":"","*":"Acronyms in healthcare"},{"ns":0,"exists":"","*":"Africa Fighting Malaria"},{"ns":0,"exists":"","*":"African Leaders Malaria Alliance"},{"ns":0,"exists":"","*":"Against Malaria Foundation"},{"ns":0,"exists":"","*":"Amazon Malaria Initiative"},{"ns":0,"exists":"","*":"Anopheles"},{"ns":0,"exists":"","*":"Antimalarial medication"},{"ns":0,"exists":"","*":"Apical membrane antigen 1"},{"ns":0,"exists":"","*":"Artemisinin"},{"ns":0,"exists":"","*":"Assays"},{"ns":0,"exists":"","*":"Bill & Melinda Gates Foundation"},{"ns":0,"exists":"","*":"Bill and Melinda Gates Foundation"},{"ns":0,"exists":"","*":"Biological life cycle"},{"ns":0,"exists":"","*":"Blackwater fever"},{"ns":0,"exists":"","*":"Blood film"},{"ns":0,"exists":"","*":"Burkina Faso"},{"ns":0,"exists":"","*":"Cerebral malaria"},{"ns":0,"exists":"","*":"Communicable disease"},{"ns":0,"exists":"","*":"DANIDA"},{"ns":0,"exists":"","*":"DDT"},{"ns":0,"exists":"","*":"Dar es Salaam"},{"ns":0,"exists":"","*":"Data Safety Monitoring Boards"},{"ns":0,"exists":"","*":"Diagnosis of malaria"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Diseases of poverty"},{"ns":0,"exists":"","*":"Duffy antigen"},{"ns":0,"exists":"","*":"Epidemiology"},{"ns":0,"exists":"","*":"Ethics committee"},{"ns":0,"exists":"","*":"European Commission"},{"ns":0,"exists":"","*":"European and Developing Countries Clinical Trials Partnership"},{"ns":0,"exists":"","*":"Extreme Blue"},{"ns":0,"exists":"","*":"G6PDH deficiency"},{"ns":0,"exists":"","*":"Gametocyte"},{"ns":0,"exists":"","*":"Genetic resistance to malaria"},{"ns":0,"exists":"","*":"Good Laboratory Practice"},{"ns":0,"exists":"","*":"Good clinical practice"},{"ns":0,"exists":"","*":"History of malaria"},{"ns":0,"exists":"","*":"Holoendemic"},{"ns":0,"exists":"","*":"Hypnozoite"},{"ns":0,"exists":"","*":"Imagine No Malaria"},{"ns":0,"exists":"","*":"Jeffrey Sachs"},{"ns":0,"exists":"","*":"Malaria"},{"ns":0,"exists":"","*":"Malaria Atlas Project"},{"ns":0,"exists":"","*":"Malaria Consortium"},{"ns":0,"exists":"","*":"Malaria No More"},{"ns":0,"exists":"","*":"Malaria and the Caribbean"},{"ns":0,"exists":"","*":"Malaria antigen detection tests"},{"ns":0,"exists":"","*":"Malaria culture"},{"ns":0,"exists":"","*":"Malaria prophylaxis"},{"ns":0,"exists":"","*":"Malaria vaccine"},{"ns":0,"exists":"","*":"Medicines for Malaria Venture"},{"ns":0,"exists":"","*":"Mefloquine"},{"ns":0,"exists":"","*":"Merozoite"},{"ns":0,"exists":"","*":"Millennium Development Goals"},{"ns":0,"exists":"","*":"Ministry of Foreign Affairs (Netherlands)"},{"ns":0,"exists":"","*":"Mosquito control"},{"ns":0,"exists":"","*":"Mosquito net"},{"ns":0,"exists":"","*":"NGO"},{"ns":0,"exists":"","*":"National Malaria Eradication Program"},{"ns":0,"exists":"","*":"Plasmodium"},{"ns":0,"exists":"","*":"Plasmodium (life cycle)"},{"ns":0,"exists":"","*":"Plasmodium falciparum"},{"ns":0,"exists":"","*":"Plasmodium knowlesi"},{"ns":0,"exists":"","*":"Plasmodium malariae"},{"ns":0,"exists":"","*":"Plasmodium ovale"},{"ns":0,"exists":"","*":"Plasmodium vivax"},{"ns":0,"exists":"","*":"Pregnancy-associated malaria"},{"ns":0,"exists":"","*":"Proguanil"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Public health"},{"ns":0,"exists":"","*":"R&D"},{"ns":0,"exists":"","*":"RTS,S"},{"ns":0,"exists":"","*":"Roll Back Malaria Partnership"},{"ns":0,"exists":"","*":"Roman Fever (disease)"},{"ns":0,"exists":"","*":"Schizont"},{"ns":0,"exists":"","*":"Sickle-cell anaemia"},{"ns":0,"exists":"","*":"South African Malaria Initiative"},{"ns":0,"exists":"","*":"Standard Operating Procedures"},{"ns":0,"exists":"","*":"Sterile insect technique"},{"ns":0,"exists":"","*":"Tanzania"},{"ns":0,"exists":"","*":"Thalassemia"},{"ns":0,"exists":"","*":"The Global Fund to Fight AIDS, Tuberculosis and Malaria"},{"ns":0,"exists":"","*":"Timeline of malaria"},{"ns":0,"exists":"","*":"Trustee"},{"ns":0,"exists":"","*":"Uganda"},{"ns":0,"exists":"","*":"Vaccine"},{"ns":0,"exists":"","*":"Vaccines"},{"ns":0,"exists":"","*":"Vector control"},{"ns":0,"exists":"","*":"World Malaria Day"},{"ns":0,"exists":"","*":"Zambia"},{"ns":0,"*":"Wen Kilama"},{"ns":0,"*":"AMANET"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"},{"ns":11,"exists":"","*":"Template talk:Malaria"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox Organization"},{"ns":10,"exists":"","*":"Template:Infobox organization"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:If empty"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Comma separated entries"},{"ns":10,"exists":"","*":"Template:Longitem"},{"ns":10,"exists":"","*":"Template:URL"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Official website"},{"ns":10,"exists":"","*":"Template:Malaria"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:If empty"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Separated entries"},{"ns":828,"exists":"","*":"Module:URL"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Official website"},{"ns":828,"exists":"","*":"Module:Navbox"}],"images":["AMANET_Logo.jpg","Saving_Lives_with_SMS_for_Life.jpg","Blue_pencil.svg"],"externallinks":["http://www.rbm.who.int/wmr2005/html/1-2.htm","https://web.archive.org/web/20080214054736/http://rbm.who.int/wmr2005/html/1-2.htm","//doi.org/10.1038/415670a","//www.ncbi.nlm.nih.gov/pubmed/11832954","//doi.org/10.1038/415680a","//www.ncbi.nlm.nih.gov/pubmed/11832956","http://www.ajtmh.org/cgi/pmidlookup?view=long&pmid=11425172","//www.ncbi.nlm.nih.gov/pubmed/11425172","http://linkinghub.elsevier.com/retrieve/pii/S0169-4758(98)01236-8","//doi.org/10.1016/S0169-4758(98)01236-8","//www.ncbi.nlm.nih.gov/pubmed/17040749","http://www.scidev.net/Opinions/index.cfm?fuseaction=readOpinions&itemid=452&language=1","http://www.ajtmh.org/cgi/content/full/77/6_Suppl/282","//www.ncbi.nlm.nih.gov/pubmed/18165504","http://clinicaltrials.gov/ct2/show/NCT00452088?spons=%22African+Malaria+Network+Trust%22&spons_ex=Y&rank=4","http://clinicaltrials.gov/ct2/show/NCT00469651?spons=%22African+Malaria+Network+Trust%22&spons_ex=Y&rank=3","http://clinicaltrials.gov/ct2/show/NCT00431808?spons=%22African+Malaria+Network+Trust%22&spons_ex=Y&rank=1","http://clinicaltrials.gov/ct2/show/NCT00424944?spons=%22African+Malaria+Network+Trust%22&spons_ex=Y&rank=2","https://archive.is/20070629153954/http://www.gatesfoundation.org/GlobalHealth/Pri_Diseases/Malaria/Grants/Grant-37350.htm","http://www.gatesfoundation.org/GlobalHealth/Pri_Diseases/Malaria/Grants/Grant-37350.htm","https://www.wikidata.org/wiki/Q4689852#P856","http://www.amanet-trust.org/"],"sections":[{"toclevel":1,"level":"2","line":"Precedence","number":"1","index":"1","fromtitle":"African_Malaria_Network_Trust","byteoffset":1161,"anchor":"Precedence"},{"toclevel":1,"level":"2","line":"Establishment","number":"2","index":"2","fromtitle":"African_Malaria_Network_Trust","byteoffset":3961,"anchor":"Establishment"},{"toclevel":1,"level":"2","line":"Mission","number":"3","index":"3","fromtitle":"African_Malaria_Network_Trust","byteoffset":4972,"anchor":"Mission"},{"toclevel":1,"level":"2","line":"Broad objective","number":"4","index":"4","fromtitle":"African_Malaria_Network_Trust","byteoffset":5090,"anchor":"Broad_objective"},{"toclevel":1,"level":"2","line":"Specific objectives","number":"5","index":"5","fromtitle":"African_Malaria_Network_Trust","byteoffset":5252,"anchor":"Specific_objectives"},{"toclevel":1,"level":"2","line":"Organization Structure","number":"6","index":"6","fromtitle":"African_Malaria_Network_Trust","byteoffset":6333,"anchor":"Organization_Structure"},{"toclevel":1,"level":"2","line":"Product research and development","number":"7","index":"7","fromtitle":"African_Malaria_Network_Trust","byteoffset":7993,"anchor":"Product_research_and_development"},{"toclevel":1,"level":"2","line":"Capacity strengthening","number":"8","index":"8","fromtitle":"African_Malaria_Network_Trust","byteoffset":10565,"anchor":"Capacity_strengthening"},{"toclevel":1,"level":"2","line":"Building institutional capacities in Health Research Ethics in Africa","number":"9","index":"9","fromtitle":"African_Malaria_Network_Trust","byteoffset":12338,"anchor":"Building_institutional_capacities_in_Health_Research_Ethics_in_Africa"},{"toclevel":1,"level":"2","line":"The Afro Immuno \u2013 Assay (AIA) Network","number":"10","index":"10","fromtitle":"African_Malaria_Network_Trust","byteoffset":14509,"anchor":"The_Afro_Immuno_\u2013_Assay_(AIA)_Network"},{"toclevel":1,"level":"2","line":"Short and long-term training","number":"11","index":"11","fromtitle":"African_Malaria_Network_Trust","byteoffset":15584,"anchor":"Short_and_long-term_training"},{"toclevel":1,"level":"2","line":"The Multilateral Initiative on Malaria (MIM)","number":"12","index":"12","fromtitle":"African_Malaria_Network_Trust","byteoffset":17546,"anchor":"The_Multilateral_Initiative_on_Malaria_(MIM)"},{"toclevel":1,"level":"2","line":"Acknowledgements","number":"13","index":"13","fromtitle":"African_Malaria_Network_Trust","byteoffset":18073,"anchor":"Acknowledgements"},{"toclevel":1,"level":"2","line":"References","number":"14","index":"14","fromtitle":"African_Malaria_Network_Trust","byteoffset":18634,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"15","index":"15","fromtitle":"African_Malaria_Network_Trust","byteoffset":22495,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"African Malaria Network Trust","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q4689852"}]}}